Eli Lilly and Co., whose best-selling schizophrenia drug Zyprexa survived a United Kingdom court challenge by generic makers
two years ago, lost a bid to dismiss another lawsuit over the medicine’s patent in Britain.
Judge Christopher Floyd in the High Court in London on Tuesday denied Lilly’s request for a judgment without trial
against Neopharma Ltd., the closely held
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment